文献速递骨肌介入CT

骨样骨瘤患者CT引导射频消融的治疗转归

Therapeutic outcome of CT-guided radiofrequency ablation in patients with osteoid osteoma.
PubMed 文献 · Skeletal Radiol · 2017-04-20

单中心回顾性研究纳入2008至2015年接受CT引导射频消融治疗的126例疑似骨样骨瘤患者,使用7mm或10mm活性端电极,关节或脊柱病灶采取特定预防措施。88例完成电话随访者总体成功率为94.3%,其中79/88(89.8%)为初次成功,4/88(4.5%)为疼痛复发后再次射频消融的二次成功,平均随访34.6个月。结论认为CT引导射频消融可有效且安全地治疗骨样骨瘤,疗效在长期随访中持续。

要点

  • 疑似骨样骨瘤经CT引导射频消融后总体成功率为94.3%(88例随访者中)。
  • 初次成功率为89.8%(79/88),疼痛复发后再次射频消融的二次成功率为4.5%(4/88)。
  • 并发症少见,包括2例轻度可逆周围神经损伤、1例臂丛神经病、1例电极尖端断裂碎片和1例肌肉血肿。

核心结论

  • 骨样骨瘤可通过所介绍的消融方案经CT引导射频消融有效且安全地治疗。
  • 治疗的有利效果在长期随访中持续存在。

研究设计与样本

  • 单中心回顾性研究,2008至2015年共126例临床怀疑且影像诊断骨样骨瘤的患者接受CT引导射频消融治疗。
  • 所有患者使用同一设备,采用7mm或10mm活性端电极。
  • 关节或脊柱骨样骨瘤病例采取特定预防措施。
  • 通过电话随访评估长期疼痛、日常活动能力(包括运动)及长期并发症。
  • 成功定义为无残余疼痛且能正常进行日常活动。

诊断标准与关键数值

  • 成功定义为无残余疼痛且能正常进行日常活动。
  • 在完成电话随访的88例患者中,总体成功率为94.3%。
  • 初次成功率为89.8%(79/88),二次成功率为4.5%(4/88)。
  • 平均随访时间为34.6个月(SD=24.7,范围3-90)。

局限性

  • 单中心回顾性研究。
  • 126例治疗患者中仅88例完成电话随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the long-term outcome of computed tomography-guided radiofrequency ablation (CT-guided RFA) in patients with suspected osteoid osteoma (OO).

MATERIALS AND METHODS: Single-center retrospective study. Patients with clinical suspicion and imaging diagnosis of osteoid osteoma were treated by CT-guided RFA using the same device with either a 7- or 10-mm active tip electrode. Specific precautions were applied in case of articular or spinal OO. Patients were contacted by phone to evaluate the long-term outcome in terms of pain, ability to perform daily activities (including sports), and long-term complications. Success was defined as the absence of residual pain and ability to perform daily activities normally.

RESULTS: From 2008 to 2015, 126 patients were treated by CT-guided RFA for OO in our institution. Mean patient age was 26.1 years (SD = 11, range 1-53); mean delay to diagnosis was 16.9 months (SD = 15.2, range 1-120). Among patients who answered the follow-up call (n = 88), the overall success rate was 94.3%: 79/88 (89.8%) had primary success of the procedure, and 4/88 (4.5%) had a secondary success (repeat-RFA after pain recurrence). Mean follow-up time was 34.6 months (SD = 24.7, range 3-90). Few complications occurred: two mild reversible peripheral nerve injuries, one brachial plexus neuropathy, one broken electrode tip fragment, and one muscular hematoma.

CONCLUSION: Osteoid osteoma can be effectively and safely treated by CT-guided RFA using the presented ablation protocol. Beneficial effects of the treatment persist at long-term follow-up.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Lassalle L, Campagna R, Corcos G, et al. Therapeutic outcome of CT-guided radiofrequency ablation in patients with osteoid osteoma. Skeletal Radiol. 2017. PMID: 28429047. doi:10.1007/s00256-017-2658-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。